AAV-Microdystrophin gene therapy for Duchenne muscular dystrophy: enhancement of immune-protection by capsid bioengineering

Project: Research

Project Details

StatusActive
Effective start/end date1/12/24 → 30/11/26

Funding

  • U.S. Army Medical Research Acquisition Activity: £145,193.73